Our Mission
The ACC Nevada Chapter is dedicated to advancing the field of cardiovascular care through innovation, advocacy, and professional development, ensuring that Nevada’s clinicians are equipped to meet the evolving health challenges of our state.
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Please join our cardiology colleagues at the ACC Annual Meeting, a premier gathering of cardiovascular professionals from around the world. This dynamic conference brings together leading physicians, researchers, healthcare innovators, and industry experts to explore the latest advances in cardiovascular medicine. Attendees will experience cutting-edge clinical education, groundbreaking research presentations, interactive learning sessions, and exceptional networking opportunities focused on improving patient care and advancing the future of heart health.
Latest in Cardiology from ACC.org
- Optimizing Dual Antiplatelet Therapy in Patients With Diabetes and Multivessel Disease Undergoing PCI: The TUXEDO-2 TrialThe TUXEDO-2 (Ultrathin Strut vs. Xience in a Diabetic Population With Multivessel Disease 2—India Study) trial demonstrated that among patients with diabetes mellitus and multivessel coronary artery disease undergoing percutaneous coronary intervention (PCI)...
- ACCEL Lite: Key Take-Home Messages From the 2025 Sports Cardiology GuidelinesIn this interview, Alison L. Bailey, MD, FACC and Aaron Baggish, MD, FACC examine the latest sports cardiology guidelines.
- QI.PI Project Grant Recipient Develops Digital Biomarker For PAD ScreeningA quick, noninvasive toe-based light measurement combined with artificial intelligence demonstrated efficacy in screening for peripheral artery disease (PAD), according to a recent study published in npj Digital Medicine by a 2024 recipient of an ACC Accreditation Services' QI.PI Project Grant.
- Racial and Sex Disparities in M-TEER Outcomes | NCDR StudyBlack patients undergoing mitral transcatheter edge-to-edge repair (M-TEER) were more likely to present with more advanced disease, had lower procedural success and higher heart failure (HF) readmission rates vs. White patients, and female patients had lower procedural success rates vs. male patients...
- Stylet-Driven vs. Non-Stylet-Driven Leads For Conduction System Pacing | NCDR StudyBoth stylet-driven and non-stylet-driven leads for conduction system pacing (CSP) exhibited high implant success and low complication rates, highlighting the safety and effectiveness of both lead types, according to a recent study published in Heart Rhythm.